Study

EORTC-1617-QLG-BCG-ROG

Follow-up in Early and Locally Advanced Breast Cancer Patients: An EORTC QLG-BCG- ROG Protocol

Study documentation Back to result

Trial Status

Closed to Patient Entry

Dates

Date of activation: 14-Oct-2020

Data management at EORTC

Yes

Design

Cohort
Not randomized / N.A.

Targeted Sample size

EORTC Groups: 830 - All Groups: 830

Treatment

None

Study Staff

  • Vesna Bjelic-Radisic (Study Coordinator), Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke, Wuppertal
  • Fatima Cardoso (Study Coordinator), ,
  • Corneel Coens (Statistician), EORTC Headquarters, Brussels
  • Abigirl Machingura (Statistician), EORTC Headquarters, Brussels
  • Coralie Poncet (Statistician), EORTC Headquarters, Brussels
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Tim Verbiest (Data Manager), EORTC Headquarters, Brussels
  • Gilles Sarlet (Regulatory Affairs Manager), EORTC Headquarters, Brussels
  • Xiao Mang Zhou (Regulatory Affairs Manager), EORTC Headquarters, Brussels
  • Christine Bourguignon (Clinical Operations Assistant), EORTC Headquarters, Brussels
  • Luigi Lim (Statistical Fellow), EORTC Headquarters, Brussels
  • Naomi Wamba (Statistical Fellow), EORTC Headquarters, Brussels

Type of cancer

  • Breast

Participating groups

  • EORTC Breast Cancer Group
  • EORTC Quality of Life Group
  • EORTC Radiation Oncology Group

Recruiting centers

  • APHP Sorbonne Univ - Hopital Tenon (PARIS, France)
  • AZORG (previous Onze Lieve Vrouw ZK) (Aalst, Belgium)
  • Barts Health NHS Trust - St. Bartholomew'S Hospital (London, United Kingdom)
  • C.H.U. Sart-Tilman (Liege, Belgium)
  • CHU Saint-Pierre-Site Porte de Hal (Brussels, Belgium)
  • CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
  • Centre de radiotherapie Marie Curie (Arras, France)
  • Clinica Universidad de Navarra-Site Madrid (Madrid, Spain)
  • Cliniques Universitaires Saint-Luc (Brussels, Belgium)
  • Fondazione IRCC San Gerardo (Monza, Italy)
  • Greater Poland Cancer Centre (Poznan, Poland)
  • Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke (Wuppertal, Germany)
  • Hirslanden Klinik-Tumor Zentrum Aarau (Aarau, Switzerland)
  • Hospital Universitario Ramon y Cajal (Madrid, Spain)
  • Hospital Universitario Reina Sofia (Cordoba, Spain)
  • Hospital Universitario de Navarra (Pamplona, Spain)
  • IRCCS - Fondazione G. Pascale (Napoli, Italy)
  • King Hussein Cancer Center (Amman, Jordan)
  • Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom)
  • Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
  • Medical University Of Gdansk (Gdansk, Poland)
  • The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
  • Tumor- und BrustZentrum Ostschweiz (St Gallen, Switzerland)
  • Univ. of Florence -Azienda Ospedaliero-Universitaria Careggi (Firenze, Italy)
  • Universita Degli Studi Di Roma La Sapienza - Ospedale Sant'Andrea (Roma, Italy)
  • Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie (Leipzig, Germany)

Protocol summary

http://clinicaltrials.gov/study/NCT03859453

NCT number

NCT03859453